Results 71 to 80 of about 413 (135)
Secukinumab for Acrodermatitis Continua of Hallopeau [PDF]
Muggli, David +4 more
openaire +4 more sources
Pustular psoriasis: pathophysiology and current treatment perspectives
Katie E Benjegerdes,1 Kimberly Hyde,2 Dario Kivelevitch,3 Bobbak Mansouri1,4 1Texas A&M Health Science Center College of Medicine, Temple, 2Texas A&M Health Science Center College of Medicine, Round Rock, 3Division of Dermatology, Baylor ...
Benjegerdes KE +3 more
doaj
Acrodermatitis continua of Hallopeau (ACH) is a rare and chronic variant of pustular psoriasis characterized by sterile pustules, periungual inflammation, and progressive nail destruction.
Man Li +4 more
doaj +1 more source
Purpose This review aims to outline the crucial role of IL-36 signaling in inflammatory skin diseases and summarize the therapeutic potential of spesolimab.
Hanlin Zhang +4 more
doaj +1 more source
Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? [PDF]
Megna M +5 more
europepmc +1 more source
Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report. [PDF]
Battista T +5 more
europepmc +1 more source
Both SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome and pustular skin diseases are characterized by neutrophil-dominated inflammatory responses; however, whether they represent manifestations within a shared disease spectrum ...
Rongzhen Xia +7 more
doaj +1 more source
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau. [PDF]
Rizzetto G +4 more
europepmc +1 more source
Background The simultaneous occurrence of generalised pustular psoriasis (GPP), acrodermatitis continua of Hallopeau (ACH), and Psoriatic arthritis (PsA) in the same patient is infrequently documented in the literature.
Ritasman Baisya +2 more
doaj +1 more source

